Case definitions & diagnostic considerations : Peri‐implant diseases and conditions (2)
How do we define a case of peri‐implantitis in day‐to‐day clinical practice and teaching situations?
- Presence of bleeding and/or suppuration on gentle probing.
- Increased probing depth compared to previous examinations.
- Presence of bone loss beyond crestal bone level changes resulting from initial bone remodeling.
- Presence of bleeding and/or suppuration on gentle probing.
- Probing depths of ≥6 mm.
- Bone levels ≥3 mm apical of the most coronal portion of the intraosseous part of the implant.
It should be noted that visual signs of inflammation can vary and that recession of the mucosal margin should be considered in the probing depth evaluation.
How do we define a case of peri‐implant health and peri‐implant mucositis in epidemiological or disease surveillance studies?
The same criteria used to define peri‐implant health and peri‐implant mucositis in day‐to‐day practice should be applied in epidemiological studies.
How do we define a case of peri‐implantitis in epidemiological or disease surveillance studies?
- Presence of bleeding and/or suppuration on gentle probing.
- Increased probing depth compared to previous examinations.
- Presence of bone loss beyond crestal bone level changes resulting from initial bone remodeling. Epidemiological studies need to take into account the error of measurements in relation to assessments of bone level changes. Bone loss should be reported using thresholds exceeding the measurement error (mean 0.5 mm).
Epidemiological studies should ideally include previous examinations performed after the first year of loading. In the absence of previous radiographic examinations, bone levels ≥3 mm apical of the most coronal portion of the intra‐osseous part of the implant together with bleeding on probing are consistent with the diagnosis of peri‐implantitis.
ACKNOWLEDGMENTS AND DISCLOSURES
Workshop participants filed detailed disclosure of potential conflicts of interest relevant to the workshop topics, and these are kept on file. The authors receive, or have received, research funding, consultant fees, and/or lecture compensation from the following companies: BioHorizons, Dentsply Sirona, Geistlich Pharma, Intra‐Lock, ITI Foundation, J. Morita, LaunchPad Medical, Maxillent, Medtronic, Osteogenics Biomedical, Osteology Foundation, Straumann, and SUNSTAR.
Serial posts:
- Peri‐implant diseases and conditions
- Introduction : Peri‐implant diseases and conditions
- Peri-implant health : Peri‐implant diseases and conditions
- Peri‐implant mucositis : Peri‐implant diseases and conditions
- Peri-implantitis : Peri‐implant diseases and conditions
- Hard‐ & soft-tissue deficiencies : Peri‐implant diseases and conditions
- Case definitions & diagnostic considerations : Peri‐implant diseases and conditions (1)
- Case definitions & diagnostic considerations : Peri‐implant diseases and conditions (2)
- Penyakit peri-implant dan ketentuan-ketentuannya
- Pendahuluan : Penyakit dan ketentuan peri‐implant
- Peri-implant saras : Penyakit dan ketentuan peri‐implant
- Mukositis peri‐implant : Penyakit & ketentuan peri‐implant
- Peri-implantitis : Penyakit dan ketentuan peri‐implant
- Kekurangan jaringan lunak & jaringan keras : Penyakit & keadaan peri‐implant
- Definisi kasus & pertimbangan diagnostik : Penyakit dan keadaan peri‐implan (1)
- Definisi kasus & pertimbangan diagnosa : Penyakit dan keadaan peri‐implant (2)